Molecular Devices to Attend ELRIG Drug Discovery 2012
Product News Aug 15, 2012
The SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform is the only user upgradeable microplate reader on the market that allows for real-time system configuration by the user in less than two minutes. The TUNE Cartridge is our latest breakthrough optical technology that combines free wavelength selection with up to 10X greater sensitivity than other monochromator-based systems. TUNE lets you optimize excitation and emission wavelengths, assay at more physiologically relevant probe concentrations and find the best fit for your application, not your reader. This revolution in modularity allows you to read what you want, when you want without compromising your biology. Although your detection needs may change, your equipment can stay the same simply by adding a new detection cartridge.
MetaXpress® 5.0 High Content Image Acquisition and Analysis Software has been designed to improve the ease and speed of custom image analysis using the ImageXpress® Micro and Ultra Systems. The new software enables user-created analysis to be run on MetaXpress® PowerCore™ Software, which harnesses the speed of parallel processing and instantly cuts analysis time from hours to minutes. An interactive tool incorporated into the software allows users to create custom analysis easily, without resorting to dedicated programming expertise. The system includes a total of 19 pre-designed analysis routines, with the facility to freely add in custom steps to create a tailored analysis. MetaXpress® 5.0 also features object click-to-find, allowing scientists to rapidly identify objects of interest within their images. Investigators can easily import data from 3rd party hardware, and export measurements to a variety of formats with the new MDCStore™ Xchange Service plug-in.
We will be hosting an ImageXpress® User Meeting on Tuesday 4th September, which will bring together both customers and those with an interest in our Imaging products. The meeting will be chaired by Dr Michael Howell, Head of High Throughput Screening at Cancer Research UK and will include presentations from AstraZeneca, University of Zurich and the University of Nottingham. Topics that will be covered include High Content Screening, G protein-coupled receptors and predictive toxicology. Registration for this event can for found here.